Alnylam Pharma (ALNY) Tops Q1 EPS by 1c
Tweet
Share
E-mail
Get Alerts ALNY Hot Sheet
Price: $266.11 --0%
Revenue Growth %: +15.3%
Financial Fact:
Comprehensive loss: -109.41M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: +15.3%
Financial Fact:
Comprehensive loss: -109.41M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Alnylam Pharma (NASDAQ: ALNY) reported Q1 EPS of ($1.25), $0.01 better than the analyst estimate of ($1.26). Revenue for the quarter came in at $19 million versus the consensus estimate of $23.65 million.
For earnings history and earnings-related data on Alnylam Pharma (ALNY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- United Natural Foods (UNFI) Tops Q4 EPS by 8c ; Offers Guidance
- QNB Corp. sells $254M in securities in portfolio repositioning
- MSC Industrial names Rob Kuhns as executive VP and CFO
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
